Top

Published in:

01-01-2012 | Urologic Oncology

Assessment of Oncologic Control Obtained After Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas (UUT-UCs): Results from a Large French Multicenter Collaborative Study

Authors: Mehdi Mokhtar Ariane, MD, Pierre Colin, MD, Adil Ouzzane, MD, Geraldine Pignot, MD, PhD, Marie Audouin, MD, Jean-Nicolas Cornu, MD, Baptiste Albouy, MD, Julien Guillotreau, MD, Yann Neuzillet, MD, PhD, Sébastien Crouzet, MD, Sophie Hurel, MD, Frederic Arroua, MD, Pierre Bigot, MD, Charles Marchand, MD, Pierre Olivier Fais, MD, Alexandre de la Taille, MD, PhD, Fabien Saint, MD, PhD, Emmanuel Ravier, MD, Alexandre Matte, MD, Laurent Guy, MD, PhD, Franck Bruyère, MD, PhD, Morgan Rouprêt, MD, PhD

Published in: Annals of Surgical Oncology | Issue 1/2012

Abstract

Background

The purpose of this study was to compare the postsurgical survival of UUT-UC patients treated with ONU and LNU.

Methods

Using a multi-institutional, national, retrospective database, we identified patients with UUT-UC who underwent radical nephroureterectomy by open access (ONU) or by the minimally invasive alternative (LNU). Survival curves were estimated using Kaplan-Meier method. A multivariate Cox model was used to evaluate the association between surgical approach and disease recurrence.

Results

Overall, 609 patients were included (ONU = 459 and LNU = 150). The median age was 69.8 years (range 61.9–76), and the male-to-female ratio was 2:1. Postoperative complications occurred in 80 patients, with no significant difference between ONU and LNU on the whole (P = 0.64). The median follow-up was 27 months. There was no difference between the 2 procedures in the 5-year CSS or 5-year RFS. Moreover, the 5-year CSS (P = 0.053) and 5-year RFS (P = 0.9) for cases with locally advanced disease (pT3/pT4) were similar between ONU and LNU. In the multivariate analysis, the surgical procedure used was not found to be associated with survival. The main limitation of the study is its retrospective design, which is the result of the rarity of the disease.

Conclusions

There is no evidence that oncological outcomes for LNU are inferior to those for open surgery, provided that the appropriate precautionary measures are taken.

Available only for authorised users

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRef

Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas (UUT-UCCs): 2011 update. Eur Urol. 2011;59:584–94.PubMedCrossRef

Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33.PubMedCrossRef

Clayman RV, Kavoussi LR, Figenshau RS, Chandhoke PS, Albala DM. Laparoscopic nephroureterectomy: initial clinical case report. J Laparoendosc Surg. 1991;1:343–9.PubMedCrossRef

Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol. 2009;56:1–9.PubMedCrossRef

Favaretto RL, Shariat SF, Chade DC, Godoy G, Kaag M, Cronin AM, et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol. 2010;58:645–51.PubMedCrossRef

Roupret M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, et al. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology. 2007;69:656–61.PubMedCrossRef

Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56:520–6.PubMedCrossRef

Berger A, Haber GP, Kamoi K, Aron M, Desai MM, Kaouk JH, et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. J Urol. 2008;180:849–54.PubMedCrossRef

10.

Rassweiler J, Tsivian A, Kumar AV, Lymberakis C, Schulze M, Seeman O, et al. Oncological safety of laparoscopic surgery for urological malignancy: experience with more than 1,000 operations. J Urol. 2003;169:2072–5.PubMedCrossRef

11.

Ong AM, Bhayani SB, Pavlovich CP. Trocar site recurrence after laparoscopic nephroureterectomy. J Urol. 2003;170:1301.PubMedCrossRef

12.

Roupret M, Smyth G, Irani J, Guy L, Davin JL, Saint F, et al. Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol. 2009;27:81–8.PubMedCrossRef

13.

Greco F, Wagner S, Hoda R M, Hamza A, Fornara P. Laparoscopic vs open radical nephroureterectomy for upper urinary tract urothelial cancer: oncological outcomes and 5-year follow-up. BJU Int. 2009;104:1274–8.PubMedCrossRef

14.

Manabe D, Saika T, Ebara S, Uehara S, Nagai A, Fujita R, et al. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology. 2007;69:457–51.CrossRef

15.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedCrossRef

16.

Roupret M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67:1181–7.PubMedCrossRef

17.

Phé V, Cussenot O, Bitker MO, Roupret M. Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? BJU Int. 2010. doi:10.1111/j.1464-410X.2010.09835.x. [Epub ahead of print].

18.

Waldert M, Remzi M, Klingler HC, Mueller L, Marberger M. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy. BJU Int. 2009;103:66–70.PubMedCrossRef

19.

Martin RC, II, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg. 2002;235:803–13.PubMedCrossRef

20.

Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, et al. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int. 2010. doi:10.1111/j.1464-410X.2010.09826.x. [Epub ahead of print].

21.

Kamihira O, Hattori R, Yamaguchi A, Kawa G, Ogawa O, Habuchi T, et al. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol. 2009;55:1397–407.PubMedCrossRef

22.

Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Sun M, Pharand D, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010;75:118–24.PubMedCrossRef

23.

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol. 2009;56:512–8.PubMedCrossRef

24.

Mullerad M, Russo P, Golijanin D, Chen HN, Tsai HH, Donat SM, et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol. 2004;172:2177–81.PubMedCrossRef

25.

Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010;75:321–7.PubMedCrossRef

26.

Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, et al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010;105:1672–7.PubMedCrossRef

Title: Assessment of Oncologic Control Obtained After Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas (UUT-UCs): Results from a Large French Multicenter Collaborative Study
Authors: Mehdi Mokhtar Ariane, MD
Pierre Colin, MD
Adil Ouzzane, MD
Geraldine Pignot, MD, PhD
Marie Audouin, MD
Jean-Nicolas Cornu, MD
Baptiste Albouy, MD
Julien Guillotreau, MD
Yann Neuzillet, MD, PhD
Sébastien Crouzet, MD
Sophie Hurel, MD
Frederic Arroua, MD
Pierre Bigot, MD
Charles Marchand, MD
Pierre Olivier Fais, MD
Alexandre de la Taille, MD, PhD
Fabien Saint, MD, PhD
Emmanuel Ravier, MD
Alexandre Matte, MD
Laurent Guy, MD, PhD
Franck Bruyère, MD, PhD
Morgan Rouprêt, MD, PhD
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 1/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-011-1841-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Assessment of Oncologic Control Obtained After Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas (UUT-UCs): Results from a Large French Multicenter Collaborative Study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Recurrence Following Hepatectomy for Metastatic Colorectal Cancer: Development of a Model that Predicts Patterns of Recurrence and Survival

Bilaterality in Papillary Thyroid Carcinoma: Does It Influence Prognosis?

Does Chemotherapy Prior to Emergency Surgery Affect Patient Outcomes? Examination of 1912 Patients

Incorporation of Adjuvant Therapy into the Multimodality Management of Gastrointestinal Stromal Tumors of the Stomach in the United States

Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients

Comparison of Clinical and Surgical-Pathological Staging in IIIA Non-Small Cell Lung Cancer Patients